These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4618720)

  • 21. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
    Lipska B; Szukalski B; Nurowska K; Welbel L
    Psychiatr Pol; 1986; 20(1):1-7. PubMed ID: 3725983
    [No Abstract]   [Full Text] [Related]  

  • 23. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
    Dencker SJ; Frankenberg K; Hansen V; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():29-40. PubMed ID: 6931471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
    Haider I
    J Pak Med Assoc; 1985 Sep; 35(9):286-9. PubMed ID: 3934417
    [No Abstract]   [Full Text] [Related]  

  • 25. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS; Yeo SH
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
    Cookson IB
    Int Clin Psychopharmacol; 1987 Apr; 2(2):141-9. PubMed ID: 3298419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
    Johnstone EC; Crow TJ; Frith CD; Carney MW; Price JS
    Lancet; 1978 Apr; 1(8069):848-51. PubMed ID: 76797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experience with depot neuroleptics].
    Arató M; Erdós A
    Orv Hetil; 1979 Apr; 120(17):1015-21. PubMed ID: 372888
    [No Abstract]   [Full Text] [Related]  

  • 29. Depot injections for affective disorders.
    Naylor GJ; Scott CR
    Br J Psychiatry; 1980 Jan; 136():105. PubMed ID: 7357213
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
    Coufal J; Novotný M
    Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the long acting neuroleptic agent flupenthixol decanoate--a review (author's transl)].
    Sieberns S
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):186-98. PubMed ID: 674354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term treatment of periodical and cyclic depressions with flupenthixol decanoate.
    Kielholz P; Terzani S; Pöldinger W
    Int Pharmacopsychiatry; 1979; 14(6):305-9. PubMed ID: 548504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression-inducing and antidepressive effects of neuroleptics. Experiences with flupenthixol and flupenthixol decanoate.
    Pöldinger W; Sieberns S
    Neuropsychobiology; 1983; 10(2-3):131-6. PubMed ID: 6674820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical physiognomy of flupentixol.
    Gunby B
    Acta Psychiatr Belg; 1974 Sep; 74(5):500-6. PubMed ID: 4471030
    [No Abstract]   [Full Text] [Related]  

  • 35. A study of flupenthixol decanoate and pipotiazine undecylenate in schizophrenics.
    Astrup C; Grimgård A; Hebnes K; Kruse-Jensen A; Lid M
    Acta Psychiatr Scand; 1974; 50(5):481-91. PubMed ID: 4156624
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics of flupentixol decanoate.
    Vranckx CH; De Schepper PJ; Hansen T
    Acta Psychiatr Belg; 1974 Sep; 74(5):529-32. PubMed ID: 4471034
    [No Abstract]   [Full Text] [Related]  

  • 37. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J; Villiger J; Hunter L
    Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two therapeutic experiments on stubborn pain in spinal cord lesions: coupling melitracen-flupenthixol and the transcutaneous nerve stimulation [proceedings].
    Heilporn A
    Paraplegia; 1978 Feb; 15(4):368-72. PubMed ID: 305021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delusions of infestation: treatment by depot injections of neuroleptics.
    Frithz A
    Clin Exp Dermatol; 1979 Dec; 4(4):485-8. PubMed ID: 535177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.